The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer
Arafath K. Najumudeen(Cancer Research UK Scotland Institute), Fatih Ceteci(Cancer Research UK Scotland Institute), Sigrid K. Fey(AstraZeneca (United Kingdom)), Grégory Hamm(AstraZeneca (United Kingdom)), Rory T. Steven(National Physical Laboratory), H. G. HALL(National Physical Laboratory), Chelsea J. Nikula(National Physical Laboratory), Alex Dexter(National Physical Laboratory), Teresa Murta(National Physical Laboratory), Alan M. Race(AstraZeneca (United Kingdom)), David Sumpton(Cancer Research UK Scotland Institute), Nikola Vlahov(Cancer Research UK Scotland Institute), David M. Gay(University of Copenhagen), John R. P. Knight(Cancer Research UK Scotland Institute), René Jackstadt(Heidelberg University), Joshua D.G. Leach(Cancer Research UK Scotland Institute), Rachel A. Ridgway(Cancer Research UK Scotland Institute), Emma Johnson(Cancer Research UK Scotland Institute), Colin Nixon(Cancer Research UK Scotland Institute), Ann Hedley(Cancer Research UK Scotland Institute), Kathryn Gilroy(Queen's University Belfast), William Clark(Queen's University Belfast), Sudhir B. Malla(Queen's University Belfast), Philip D. Dunne(AstraZeneca (United Kingdom)), Giovanny Rodriguez Blanco(Cancer Research UK Scotland Institute), Susan E. Critchlow(AstraZeneca (United Kingdom)), Agata Mrowinska(Cancer Research UK Scotland Institute), Gaurav Malviya(Cancer Research UK Scotland Institute), D. Solovyev(Cancer Research UK Scotland Institute), Gavin Brown(Cancer Research UK Scotland Institute), David Y. Lewis(Cancer Research UK Scotland Institute), Gillian Mackay(Cancer Research UK Scotland Institute), Douglas Strathdee(Cancer Research UK Scotland Institute), Saverio Tardito(Cancer Research UK Scotland Institute), Eyal Gottlieb(AstraZeneca (United Kingdom)), Andrew D. Campbell(National Physical Laboratory), Arafath K. Najumudeen(National Physical Laboratory), Alan M. Race(AstraZeneca (United Kingdom)), Ian S. Gilmore(National Physical Laboratory), G. McMahon(National Physical Laboratory), Paul Grant(National Physical Laboratory), Bin Yan(National Physical Laboratory), Adam Taylor(National Physical Laboratory), Efstathios A. Elia(National Physical Laboratory), Spencer A. Thomas(National Physical Laboratory), Catherine Munteanu(National Physical Laboratory), Ala Al-Afeef(National Physical Laboratory), Amy Burton(National Physical Laboratory), Jean‐Luc Vorng(National Physical Laboratory), Xavier Loizeau(National Physical Laboratory), Weiwei Zhou(National Physical Laboratory), Ammar Nasif(National Physical Laboratory), Ariadna Gonzalez(National Physical Laboratory), Hanifa Koquna(National Physical Laboratory), Martin Metodiev(National Physical Laboratory), Melina Kyriazi(National Physical Laboratory), Junting Zhang(National Physical Laboratory), Lucas Zeiger(Cancer Research UK Scotland Institute), Johan Vande Voorde(Cancer Research UK Scotland Institute), Jennifer P. Morton(Cancer Research UK Scotland Institute), Dmitry A. Soloviev(Cancer Research UK Scotland Institute), Vincen Wu(Imperial College London), Yuchen Xiang(Imperial College London), Daniel McGill(Imperial College London), Stefania Maneta-Stravrakaki(The Francis Crick Institute), Jaynisha Mistry(The Francis Crick Institute), Emine Kazanç(The Francis Crick Institute), Mariia Yuneva(The Francis Crick Institute), Yulia Panina(The Francis Crick Institute), Chandan Seth Nanda(AstraZeneca (United Kingdom)), Peter Kreuzaler(AstraZeneca (United Kingdom)), Avinash Ghanate(University of Cambridge), Stephanie Ling(AstraZeneca (United Kingdom)), Jack Richings(AstraZeneca (United Kingdom)), Kevin M. Brindle(Institute of Cancer Research), Anastasia Tsyben(Institute of Cancer Research), George Poulogiannis(Institute of Cancer Research), Amit Gupta(Institute of Cancer Research), Aurélien Tripp(Institute of Cancer Research), Evi Karali(Institute of Cancer Research), Nikos Koundouros(Institute of Cancer Research), Thanasis Tsalikis(Institute of Cancer Research), John L. Marshall(Barts Health NHS Trust), Magali Garrett(AstraZeneca (United Kingdom)), Harry Hall(Cancer Research UK Scotland Institute), Zoltán Takáts(National Physical Laboratory), Simon T. Barry(AstraZeneca (United Kingdom)), Richard J. A. Goodwin(AstraZeneca (United Kingdom)), Josephine Bunch(National Physical Laboratory), Martin Bushell(Cancer Research UK Scotland Institute), Andrew D. Campbell(Cancer Research UK Scotland Institute), Owen J. Sansom(Beatson West of Scotland Cancer Centre)
Cited by 328Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis